BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 26, 2018
Finance

Rempex remix

...also executives at anti-infectives company Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Dec 8, 2014
Company News

Cortendo management update

...Gothenburg, Sweden Business: Endocrine/Metabolic Hired: Ruth Thieroff-Ekerdt as CMO, effective Dec. 15, formerly CMO of Aptalis Pharma Inc....
BioCentury | Jan 20, 2014
Clinical News

Photofrin porfimer sodium: SPA received

...the product is approved to treat non-small cell endobronchial early carcinoma. Pinnacle acquired Photofrin from Axcan...
BioCentury | Jan 9, 2014
Top Story

Forest to acquire Aptalis

...firm TPG was unable to secure a bidder to acquire Aptalis. TPG acquired Aptalis (formerly Axcan...
BioCentury | Dec 27, 2013
Top Story

Aptalis files for $500 million IPO

...after private equity firm TPG was unable to secure a bidder to acquire Aptalis (formerly Axcan...
BioCentury | Dec 16, 2013
Company News

Aptalis Pharma, NovaMedica deal

...LLC (Princeton, N.J.) and Russian nanotechnology fund Rusnano (Moscow, Russia) (see BioCentury, Nov. 19, 2012). Aptalis Pharma Inc....
BioCentury | Oct 25, 2013
Financial News

Aptalis rumored to be planning IPO after lack of bidder

...Gastrointestinal company Aptalis Pharma Inc. (Mont-Saint-Hilaire, Quebec) could not be reached for comment on rumors that the company...
...firm TPG was unable to secure a bidder to acquire Aptalis. TPG acquired Aptalis (formerly Axcan...
BioCentury | Oct 7, 2013
Analyst Picks & Changes

Analyst picks & changes

...role" as second-line therapy in PBC, as the current standard of care, Urso ursodiol from Aptalis Pharma Inc....
Items per page:
1 - 10 of 325
BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 26, 2018
Finance

Rempex remix

...also executives at anti-infectives company Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Dec 8, 2014
Company News

Cortendo management update

...Gothenburg, Sweden Business: Endocrine/Metabolic Hired: Ruth Thieroff-Ekerdt as CMO, effective Dec. 15, formerly CMO of Aptalis Pharma Inc....
BioCentury | Jan 20, 2014
Clinical News

Photofrin porfimer sodium: SPA received

...the product is approved to treat non-small cell endobronchial early carcinoma. Pinnacle acquired Photofrin from Axcan...
BioCentury | Jan 9, 2014
Top Story

Forest to acquire Aptalis

...firm TPG was unable to secure a bidder to acquire Aptalis. TPG acquired Aptalis (formerly Axcan...
BioCentury | Dec 27, 2013
Top Story

Aptalis files for $500 million IPO

...after private equity firm TPG was unable to secure a bidder to acquire Aptalis (formerly Axcan...
BioCentury | Dec 16, 2013
Company News

Aptalis Pharma, NovaMedica deal

...LLC (Princeton, N.J.) and Russian nanotechnology fund Rusnano (Moscow, Russia) (see BioCentury, Nov. 19, 2012). Aptalis Pharma Inc....
BioCentury | Oct 25, 2013
Financial News

Aptalis rumored to be planning IPO after lack of bidder

...Gastrointestinal company Aptalis Pharma Inc. (Mont-Saint-Hilaire, Quebec) could not be reached for comment on rumors that the company...
...firm TPG was unable to secure a bidder to acquire Aptalis. TPG acquired Aptalis (formerly Axcan...
BioCentury | Oct 7, 2013
Analyst Picks & Changes

Analyst picks & changes

...role" as second-line therapy in PBC, as the current standard of care, Urso ursodiol from Aptalis Pharma Inc....
Items per page:
1 - 10 of 325